Graft-<i>versus</i>-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT

Survival after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for severe idiopathic aplastic anemia (SAA) has improved in recent years, approaching 75% at 5 years. However, an SAA-adapted composite endpoint, graft-versus-host disease (GvHD) and relapse/rejection-free survival (GRFS)...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Raynier Devillier, Dirk-Jan Eikema, Carlo Dufour, Mahmoud Aljurf, Depei Wu, Alexei Maschan, Alexander Kulagin, Constantijn J.M. Halkes, Matthew Collin, John Snowden, Cécile Renard, Arnold Ganser, Karl-Walter Sykora, Brenda E Gibson, Johan Maertens, Maija Itäla-Remes, Paola Corti, Jan Cornelissen, Martin Bornhäuser, Mercedes Colorado Araujo, Hakan Ozdogu, Antonio Risitano, Gerard Socie, Regis Peffault de Latour
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Ferrata Storti Foundation 2023-03-01
Seri Bilgileri:	Haematologica
Online Erişim:	https://haematologica.org/article/view/11024
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!